Agio Pharmaceuticals Limited Secnidazole Export Data — India (DGFT 2022–2026)

Name: Agio Pharmaceuticals Limited Secnidazole Export Records India — #14 Exporter, 12 Shipments, $150.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Secnidazole

India Pharmaceutical Trade Intelligence

$30.3M115 Suppliers77 CountriesHS 30049024

ExportsIndia → GUATEMALA54.1%India → TANZANIA18.4%

ImportsFRANCE → India$1.1K

#1 Supplier: CAPLIN POINT #1 Buyer: NUEVOS ETICOS

Agio Pharmaceuticals Limited — Secnidazole Exporter #14 | $150.7K Trade Value | TransData Nexus | TransData Nexus

Agio Pharmaceuticals Limited — Secnidazole Exporter Profile

Indian Pharmaceutical Exporter · #14 for Secnidazole · $150.7K export value · DGFT Verified

Agio Pharmaceuticals Limited is the #14 Indian exporter of Secnidazole with $150.7K in export value and 12 verified shipments. Agio Pharmaceuticals Limited holds a 0.5% market share in Secnidazole exports across 2 countries. The company exports 15 pharmaceutical products worth $11.9M across 8 therapeutic categories.

Agio Pharmaceuticals Limited — Secnidazole Export Profile: Buyers & Destinations

Agio Pharmaceuticals Limited Secnidazole export treemap — buyers and destination countries | TransData Nexus

Where Does Agio Pharmaceuticals Limited Export Secnidazole?

Country	Value	Shipments	Share
KENYA	$96.2K	7	63.9%
UGANDA	$54.4K	5	36.1%

Agio Pharmaceuticals Limited exports Secnidazole to 2 countries. The largest destination is KENYA accounting for 63.9% of Agio Pharmaceuticals Limited's Secnidazole shipments. These destinations reflect Agio Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Secnidazole from Agio Pharmaceuticals Limited?

What Secnidazole Formulations Does Agio Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
AGISEC 1 GM SECNIDAZOLE TABLETS 1 G	$65.5K	2
AGISEC 1GM (SECNIDAZOLE TABLETS)	$43.6K	4
AGISEC 1 GM (SECNIDAZOLE TABLETS 1 G)	$13.4K	1
AGISEC 1GM SECNIDAZOLE TABLETS 1 G	$10.8K	1
AGISEC 1GM (SECNIDAZOLE TABLETS 1 G)	$10.7K	3
AGISEC 1 GM (SECNIDAZOLE TABLETS 1 G)	$6.6K	1

Agio Pharmaceuticals Limited exports 6 distinct Secnidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AGISEC 1 GM SECNIDAZOLE TABLETS 1 G with 2 shipments worth $65.5K.

How Does Agio Pharmaceuticals Limited Compare to Nearest Secnidazole Exporters?

Exporters ranked immediately above and below #14 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
12	ALICE PHARMA PRIVATE LIMITED	$187.1K	11	2	$17.0K
13	TRIDENT LIFELINE LIMITED	$152.5K	10	2	$15.2K
14	AGIO PHARMACEUTICALS LIMITED ★	$150.7K	12	2	$12.6K
15	STRIDES PHARMA SCIENCE LIMITED	$115.2K	3	1	$38.4K

Agio Pharmaceuticals Limited ranks #14 among 115 Indian Secnidazole exporters. Average shipment value of $12.6K compared to the market average of $77.0K. The closest competitors by value are ALICE PHARMA PRIVATE LIMITED and TRIDENT LIFELINE LIMITED.

Which Indian Ports Ship Secnidazole Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	75	11.5%
SAHAR AIR	59	9.0%
SAHAR AIR CARGO ACC (INBOM4)	57	8.7%
JNPT/ NHAVA SHEVA SEA	46	7.1%
DELHI AIR	46	7.1%
JNPT	34	5.2%
DELHI AIR CARGO ACC (INDEL4)	31	4.8%
AHEMDABAD ICD	22	3.4%

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Secnidazole Exports

Recent geopolitical developments have introduced complexities into the pharmaceutical export landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential losses for Indian exporters. According to Pharmaceutical Commerce, maritime carriers' booking suspensions and diversions around the Cape of Good Hope are elongating lead times and pressurizing Suez-linked lanes, disproportionately impacting time-sensitive pharmaceutical replenishment cycles. This situation poses challenges for Agio Pharmaceuticals, particularly in maintaining timely deliveries to key markets.

In the United States, recent tariff implementations have affected a significant portion of Indian exports. The Federation of Indian Export Organisations highlighted that the latest U.S. tariffs impact nearly 55% of India's outbound shipments to America, placing Indian exporters at a competitive disadvantage. For Agio, which relies on the U.S. market, these tariffs could necessitate strategic adjustments to pricing and supply chain logistics.

The European Union's stringent regulatory changes, including the Falsified Medicines Directive, demand enhanced compliance measures from exporters. Agio's ability to adapt to these evolving standards will be crucial in sustaining its market presence in the EU.

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA increasing inspections of manufacturing facilities. India, hosting over 600 US FDA-approved sites, faces challenges in maintaining compliance. The US FDA conducted more than 200 inspections in 2023, with plans to increase this number in 2024. For Agio Pharmaceuticals, ensuring adherence to Good Manufacturing Practices (GMP) and other quality standards is imperative to avoid potential export bans or reputational damage.

Additionally, the prevalence of counterfeit drugs has raised concerns about India's reputation as a reliable supplier. Agio must implement robust quality control systems and transparent governance to navigate this landscape effectively.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Secnidazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Agio Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 12 individual customs records matching Agio Pharmaceuticals Limited exporting Secnidazole, covering 6 formulations to 2 countries via 3 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 77+ countries, 239+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Secnidazole

Secnidazole

Agio Pharmaceuticals Limited — Secnidazole Exporter Profile

Agio Pharmaceuticals Limited — Secnidazole Export Profile: Buyers & Destinations

Where Does Agio Pharmaceuticals Limited Export Secnidazole?

Who Are the Top Buyers of Secnidazole from Agio Pharmaceuticals Limited?

What Is India's Total Secnidazole Export Value and How Much Does Agio Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Agio Pharmaceuticals Limited's Secnidazole Exports?

How Does Agio Pharmaceuticals Limited Compare to Other Indian Secnidazole Exporters?

What Secnidazole Formulations Does Agio Pharmaceuticals Limited Export?

How Does Agio Pharmaceuticals Limited Compare to Nearest Secnidazole Exporters?

Which Indian Ports Ship Secnidazole Exports?

Geopolitical & Trade Policy Impact on Agio Pharmaceuticals Limited's Secnidazole Exports

Agio Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Agio Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Secnidazole Export Data from Agio Pharmaceuticals Limited

Secnidazole Stats

Company Overview

Top Products by Agio Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source

Buyer	Country	Value	Orders
TO THE ORDER OF	KENYA	$65.5K	2
ROYAL PHARMA 2011 LIMITED	UGANDA	$65.1K	8
TO THE ORDER OF SYNERMED	KENYA	$20.1K	2